T

Twist Bioscience

Silicon-Based DNA Synthesis

South San Francisco, CA
1,000+

About Twist Bioscience

Industry: Synthetic Biology/Genomics
Founded: 2013
Founders: Emily Leproust, Bill Banyai, Bill Peck
Status: Public (NASDAQ: TWST)

Funding & Growth

Total Raised: $800M+
Valuation: $2B+ market cap
Stage: Public
Key Investors:
Illumina ARCH Venture Polaris Partners

✓ Pros

  • • Revolutionary DNA synthesis platform
  • • Diverse product portfolio
  • • Bay Area biotech hub
  • • High-growth company
  • • Innovative technology

✗ Cons

  • • Fast-paced/demanding culture
  • • Some management challenges
  • • Work-life balance concerns
  • • Rapid scaling growing pains

Get weekly job alerts